Trial · NCT07909161
Team-Based Shared Decision-Making Program in Hypertension Control (Healthy Heart - BP Program)
NCT07909161, Not applicable, Not yet recruiting, Johns Hopkins University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Team-Based Shared Decision-Making Program in Hypertension Control (Healthy Heart - BP Program). Trials, record NCT07909161. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909161
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Team-Based Shared Decision-Making Program in Hypertension Control (Healthy Heart - BP Program)
- NCT number
- NCT07909161
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 90 participants, estimated
- Lead sponsor
- Johns Hopkins University
- Conditions
- Hypertension (HTN), Blood Pressure
- Interventions
Pharmacist-led Team-Based SDM on health behavior change and medication management for HTN control, Nurse-led Team-Based SDM on health behavior change and medication management for HTN control, Telehealth SDM visits focus on medication management and health behavior change, Self-monitored health behaviors and medications via Healthy Heart, Self-measured blood pressure (SMBP), Care partners (family/caregivers) support
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recruitment rate | 12 weeks | Percentage of eligible participants who enroll in the study. |
| Primary | Retention rate | 12 weeks | Percentage of participants who complete the intervention and follow-up assessments. |
| Primary | Survey completion rate | 12 weeks | Proportion of participants completing baseline and follow-up surveys. |
| Primary | Intervention completion rate | 12 weeks | Proportion of participants who receive the shared decision-making intervention as intended. |
| Primary | Pharmacist/Nurse Intervention Fidelity Rate | 12 weeks | Extent to which the decision aid and associated intervention components are delivered as planned. |
| Primary | Systolic blood pressure (SBP) | 12 weeks | Change in systolic blood pressure (mmHg) from baseline to 12-week follow-up |
| Secondary | Medication adherence as assessed by the Medication Adherence Report Scale-10 (MARS-10) | 12 weeks | Scores range from 0 to 50, or 0 to 10 depending on the exact scoring format used. Higher scores consistently indicate a higher level of medication adherence. |
| Secondary | Shared Decision-Making (SDM) level as assessed by the CollaboRATE survey | 12 weeks | Shared Decision-Making (SDM) level will be measured by the CollaboRATE survey. The CollaboRATE scores range from 0-27, with higher scores indicating better SDM level. |
| Secondary | Patients' perceptions of involvement in shared decision-making as assessed by the Patient SDM Questionnaire (SDM-Q-9) | 12 weeks | Mean scores of patients' perceptions of involvement in SDM assessed by the Patient SDM Questionnaire (SDM-Q-9). Scores range from 0 to 45, and higher scores indicate better involvement in SDM. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909161
GET https://conductscience.org/api/trials/v1/NCT07909161/registered